RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Memory Disorders
Accession: DOID:9008023
browse the term
Definition: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
Synonyms: exact_synonym: Age Related Memory Disorders; Age-Related Memory Disorder; Cognitive Retention Disorder; Cognitive Retention Disorders; Memory Deficit; Memory Deficits; Memory Disorder; Memory Loss; Memory Losses; Semantic Memory Disorder; Semantic Memory Disorders; Spatial Memory Disorder; Spatial Memory Disorders; memory impairment
related_synonym: MEMORY IMPAIRMENT, SUSCEPTIBILITY TO
primary_id: MESH:D008569
xref: EFO:0001072
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
treatment
ISO
RGD
PMID:18559370
RGD:8693418
NCBI chr 1:270,761,641...270,906,708
Ensembl chr 1:270,761,668...270,906,708
G
ACE
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
ISO
RGD
PMID:21864581
RGD:6893483
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
G
ACHE
acetylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18599028
NCBI chr 3:8,732,451...8,738,274
Ensembl chr 3:8,732,441...8,738,605
G
ADK
adenosine kinase
ISO
RGD
PMID:22521820
RGD:6482646
NCBI chr14:76,836,072...77,320,586
Ensembl chr14:76,836,095...77,322,416
G
ADRA1A
adrenoceptor alpha 1A
ISO
associated with brain injuries
RGD
PMID:20974230
RGD:5688366
NCBI chr14:10,623,391...10,733,378
Ensembl chr14:10,626,293...10,733,068
G
AGAP2
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
ISO
RGD
PMID:21632930
RGD:13838852
NCBI chr 5:23,015,777...23,035,943
Ensembl chr 5:23,017,176...23,033,517
G
AKAP5
A-kinase anchoring protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18711127
NCBI chr 7:88,538,938...88,544,330
Ensembl chr 7:88,538,984...88,547,392
G
AKT1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:29157831
RGD:401940181
G
ANAPC2
anaphase promoting complex subunit 2
ISO
RGD
PMID:21191042
RGD:14696672
G
APOE
apolipoprotein E
ISO
DNA:missense mutations, haplotypes:cds:p.C112R, p.R158C (human)
RGD
PMID:8584214 PMID:11714102
RGD:12904706 RGD:1578426
NCBI chr 6:51,373,113...51,375,333
Ensembl chr 6:51,372,292...51,375,330
G
APP
amyloid beta precursor protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15364477 PMID:18191838 PMID:18599028 PMID:19664757 PMID:19770021 PMID:20816828 PMID:22484447 PMID:23827522 PMID:24858312 PMID:25213453 PMID:25881725 PMID:26420483 PMID:26480858 PMID:27306655 PMID:27567873 PMID:28448946 PMID:29729307 PMID:35247505 More...
NCBI chr13:189,434,854...189,716,120
Ensembl chr13:189,435,094...189,716,056
G
AVP
vasopressin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11553362
NCBI chr17:32,581,234...32,583,145
Ensembl chr17:32,581,234...32,583,185
G
BCL2
BCL2 apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17967740
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
BDNF
brain derived neurotrophic factor
treatment
ISO
ClinVar Annotator: match by term: Memory impairment, susceptibility to associated with Subarachnoid Hemorrhage
ClinVar RGD
PMID:12140781 PMID:12161822 PMID:12553913 PMID:12836135 PMID:12888803 PMID:15115760 PMID:15337662 PMID:16152572 PMID:16172806 PMID:16222333 PMID:16344533 PMID:16389585 PMID:20075215 PMID:24033266 PMID:25741868 PMID:26822402 PMID:28492532 PMID:29157831 PMID:29704550 More...
RGD:401940181 RGD:401960858 RGD:401960859
NCBI chr 2:32,623,668...32,679,293
Ensembl chr 2:32,624,048...32,679,765
G
CACNA1D
calcium voltage-gated channel subunit alpha1 D
ISO
RGD
PMID:12591156
RGD:704382
NCBI chr13:35,568,534...35,911,483
Ensembl chr13:35,436,519...35,909,662
G
CALY
calcyon neuron specific vesicular protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30753204
NCBI chr14:141,307,092...141,316,460
Ensembl chr14:141,307,684...141,316,292
G
CHD1
chromodomain helicase DNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30728766
NCBI chr 2:105,113,149...105,205,303
Ensembl chr 2:105,113,668...105,203,119
G
CHRM1
cholinergic receptor muscarinic 1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12483218 PMID:21682298
RGD:734777
NCBI chr 2:8,858,765...8,872,042
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18848931
NCBI chr 1:142,803,697...142,937,124
Ensembl chr 1:142,803,701...142,937,123
G
CNR1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29294249
NCBI chr 1:56,466,022...56,493,275
Ensembl chr 1:56,467,835...56,492,602
G
COMT
catechol-O-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28195063
NCBI chr14:51,384,729...51,403,997
Ensembl chr14:51,385,738...51,403,998
G
CPE
carboxypeptidase E
ISO
RGD
PMID:18570185
RGD:6483325
NCBI chr 8:43,568,744...43,695,475
Ensembl chr 8:43,565,054...43,696,268
G
CREB1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased expression:hippocampus associated with alcohol use disorder;mRNA:decreased expression:hippocampus associated with morphine dependence associated with Subarachnoid Hemorrhage
RGD
PMID:14670355 PMID:16598705 PMID:26822402 PMID:29157831 PMID:29704550 PMID:34427953 More...
RGD:10059396 RGD:401940181 RGD:401959600 RGD:401959605 RGD:401960858 RGD:401960859
NCBI chr15:110,705,548...110,773,037
Ensembl chr15:110,705,496...110,771,728
G
CX3CR1
C-X3-C motif chemokine receptor 1
ISO
RGD
PMID:23855980
RGD:9491766
NCBI chr13:23,944,386...23,957,567
Ensembl chr13:23,944,369...23,957,486
G
DRD2
dopamine receptor D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21592505
NCBI chr 9:41,068,618...41,135,262
Ensembl chr 9:41,068,779...41,133,599
G
EGR1
early growth response 1
treatment
ISO
associated with Congenital Hypothyroidism
RGD
PMID:22192600
RGD:10395310
NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296
G
GABRA5
gamma-aminobutyric acid type A receptor subunit alpha5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20180861
NCBI chr 1:140,486,107...140,568,204
Ensembl chr 1:140,486,104...140,567,894
G
GIT1
GIT ArfGAP 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21499268
NCBI chr12:45,768,172...45,783,652
Ensembl chr12:45,768,176...45,783,658
G
GRPR
gastrin releasing peptide receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17097693
NCBI chr X:12,654,059...12,711,417
Ensembl chr X:12,659,776...12,696,103
G
HDAC2
histone deacetylase 2
treatment
ISO
RGD
PMID:22388814
RGD:9590324
NCBI chr 1:79,867,713...79,901,597
Ensembl chr 1:79,863,094...79,901,585
G
HIF1A
hypoxia inducible factor 1 subunit alpha
treatment
ISO
RGD
PMID:22547371
RGD:10402407
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
G
HRH3
histamine receptor H3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16488453
NCBI chr17:61,622,865...61,627,278
Ensembl chr17:61,622,938...61,627,278
G
HTR1A
5-hydroxytryptamine receptor 1A
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12591222 PMID:25817367
RGD:405866362
NCBI chr16:42,479,812...42,484,365
Ensembl chr16:42,478,923...42,484,304
G
HTR2A
5-hydroxytryptamine receptor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29294249
NCBI chr11:20,555,939...20,620,225
Ensembl chr11:20,555,963...20,619,625
G
HTR6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19733250
NCBI chr 6:78,077,358...78,092,211
G
HTR7
5-hydroxytryptamine receptor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21859099
NCBI chr14:102,443,312...102,548,894
Ensembl chr14:102,444,588...102,548,907
G
IGF1
insulin like growth factor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34632857
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
G
IGF2
insulin like growth factor 2
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:21270887 PMID:24012657
RGD:10402554
NCBI chr 2:1,469,183...1,496,417
G
INS
insulin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9264093
NCBI chr 2:1,496,842...1,498,052
Ensembl chr 2:1,496,842...1,497,841
G
KL
klotho
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25309793 PMID:25550330
NCBI chr11:9,427,236...9,479,251
Ensembl chr11:9,427,037...9,479,228
G
LNPEP
leucyl and cystinyl aminopeptidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11730987
NCBI chr 2:103,568,366...103,659,589
Ensembl chr 2:103,567,602...103,661,070
G
LOC110258578
interleukin-1 beta-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21290410
G
MAGI2
membrane associated guanylate kinase, WW and PDZ domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25653350
NCBI chr 9:100,846,693...102,171,199
Ensembl chr 9:100,847,013...102,170,004
G
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
associated with Subarachnoid Hemorrhage
RGD
PMID:26822402 PMID:29157831
RGD:401940181 RGD:401960859
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
associated with Subarachnoid Hemorrhage
RGD
PMID:26822402 PMID:29157831
RGD:401940181 RGD:401960859
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MAPT
microtubule associated protein tau
ISO
ClinVar Annotator: match by term: Memory impairment
ClinVar
PMID:7783864 PMID:7936288 PMID:8940276 PMID:9088499 PMID:9392579 PMID:9641683 PMID:10202939 PMID:10329720 PMID:10443890 PMID:10446810 PMID:11255441 PMID:11402146 PMID:11641718 PMID:11708988 PMID:11912108 PMID:11971081 PMID:11971082 PMID:12847166 PMID:14755449 PMID:15372253 PMID:15950767 PMID:17923640 PMID:18525295 PMID:19365643 PMID:19766248 PMID:19786698 PMID:19884572 PMID:19914360 PMID:20045477 PMID:23680655 PMID:23885714 PMID:25683866 PMID:25741868 PMID:26136155 PMID:26467025 PMID:26528178 PMID:27594586 PMID:28097206 PMID:28492532 PMID:31810826 More...
NCBI chr12:17,098,259...17,211,483
Ensembl chr12:17,095,587...17,211,373
G
MDK
midkine
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19217924
NCBI chr 2:16,130,787...16,133,791
Ensembl chr 2:16,130,788...16,133,510
G
MIF
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20177408
NCBI chr14:49,840,303...49,841,063
Ensembl chr14:49,840,305...49,841,068
G
NCAM1
neural cell adhesion molecule 1
treatment
ISO
associated with alcohol use disorder
RGD
PMID:16207289
RGD:401959613
NCBI chr 9:40,628,602...40,960,605
Ensembl chr 9:40,628,631...40,960,591
G
NOS1
nitric oxide synthase 1
ISO
associated with Status Epilepticus
RGD
PMID:17549628
RGD:1642140
NCBI chr14:35,112,898...35,299,297
Ensembl chr14:35,113,184...35,295,944
G
NPY
neuropeptide Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2611661
NCBI chr18:47,985,796...47,993,726
Ensembl chr18:47,985,725...47,992,667
G
NQO2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20861374
NCBI chr 7:1,792,745...1,805,916
Ensembl chr 7:1,792,876...1,806,301
G
NR3C1
nuclear receptor subfamily 3 group C member 1
treatment
ISO
RGD
PMID:23159706
RGD:408364992
NCBI chr 2:144,822,937...144,956,451
Ensembl chr 2:144,822,939...144,956,451
G
NTF4
neurotrophin 4
ISO
RGD
PMID:10869436
RGD:737722
NCBI chr 6:54,271,244...54,288,846
Ensembl chr 6:54,271,246...54,274,092
G
PNOC
prepronociceptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10401555
NCBI chr14:12,101,223...12,134,174
Ensembl chr14:12,101,698...12,133,778
G
PRKN
parkin RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12915482
NCBI chr 1:5,698,508...6,731,132
Ensembl chr 1:5,465,312...6,730,872
G
PRL
prolactin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36100143
NCBI chr 7:17,451,367...17,463,771
Ensembl chr 7:17,451,367...17,463,710
G
PSEN1
presenilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25213453 PMID:27567873 PMID:28448946
NCBI chr 7:96,478,179...96,567,884
Ensembl chr 7:96,478,190...96,569,130
G
REL
REL proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20477932
NCBI chr 3:80,861,862...80,912,233
Ensembl chr 3:80,872,255...80,911,939
G
SIGMAR1
sigma non-opioid intracellular receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15451042
NCBI chr10:32,160,767...32,163,540
Ensembl chr10:32,160,822...32,164,718
G
SLC17A6
solute carrier family 17 member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21295146
NCBI chr 2:37,098,983...37,138,935
Ensembl chr 2:37,098,992...37,138,475
G
SLC17A7
solute carrier family 17 member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21295146
NCBI chr 6:54,511,121...54,521,616
Ensembl chr 6:54,511,124...54,521,611
G
SLC6A3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17992686
NCBI chr16:79,186,114...79,220,302
Ensembl chr16:79,186,108...79,220,297
G
SLC6A4
solute carrier family 6 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18661256 PMID:18686203
NCBI chr12:46,285,995...46,328,377
Ensembl chr12:46,285,997...46,314,378
G
SPHK2
sphingosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24859201
NCBI chr 6:53,982,911...53,986,779
Ensembl chr 6:53,979,012...53,986,768
G
STAT3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17928813
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
SYP
synaptophysin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21295146
NCBI chr X:43,232,190...43,246,764
Ensembl chr X:43,232,192...43,246,680
G
TYROBP
transmembrane immune signaling adaptor TYROBP
ISO
ClinVar Annotator: match by term: Memory impairment
ClinVar
PMID:9536098 PMID:17576681 PMID:25741868 PMID:28492532 PMID:29930232
NCBI chr 6:45,309,199...45,312,562
Ensembl chr 6:45,309,201...45,312,539
G
VEGFA
vascular endothelial growth factor A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20801723
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
APP
amyloid beta precursor protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12642396
NCBI chr13:189,434,854...189,716,120
Ensembl chr13:189,435,094...189,716,056
G
ARC
activity regulated cytoskeleton associated protein
treatment
ISO
RGD
PMID:24012642
RGD:401938610
NCBI chr 4:1,517,986...1,521,403
Ensembl chr 4:1,518,180...1,519,370
G
AVP
vasopressin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7562510
NCBI chr17:32,581,234...32,583,145
Ensembl chr17:32,581,234...32,583,185
G
BCHE
butyrylcholinesterase
ISO
RGD
PMID:21771623
RGD:5688134
NCBI chr13:104,946,732...105,007,568
G
BDNF
brain derived neurotrophic factor
treatment
ISO
protein:decreased expression:amygdala, hippocampus, prefrontal cortex
RGD
PMID:25061594 PMID:28716085 PMID:31400468
RGD:10059361 RGD:401960865 RGD:401960871
NCBI chr 2:32,623,668...32,679,293
Ensembl chr 2:32,624,048...32,679,765
G
CARTPT
CART prepropeptide
treatment
ISO
associated with morphine withdrawal syndrome
RGD
PMID:32198124
RGD:407571681
NCBI chr16:48,043,558...48,045,592
Ensembl chr16:48,043,492...48,045,592
G
CREB1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased phosphorylation:amygdala, hippocampus, prefrontal cortex
RGD
PMID:28716085 PMID:31400468
RGD:401960865 RGD:401960871
NCBI chr15:110,705,548...110,773,037
Ensembl chr15:110,705,496...110,771,728
G
CSF2
colony stimulating factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8877002
NCBI chr 2:134,354,724...134,357,155
Ensembl chr 2:134,354,724...134,357,155
G
DRD3
dopamine receptor D3
ISO
RGD
PMID:15619116
RGD:7175071
NCBI chr13:145,769,294...145,817,997
Ensembl chr13:145,771,774...145,819,168
G
GJA1
gap junction protein alpha 1
ISO
RGD
PMID:22665389
RGD:7207267
NCBI chr 1:40,988,818...41,002,129
Ensembl chr 1:40,988,528...41,002,156
G
GNAI1
G protein subunit alpha i1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11350863
NCBI chr 9:100,187,878...100,272,274
Ensembl chr 9:100,187,843...100,272,532
G
GNAI3
G protein subunit alpha i3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11350863
NCBI chr 4:110,527,363...110,579,331
Ensembl chr 4:110,525,546...110,579,053
G
GRP
gastrin releasing peptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11564462
NCBI chr 1:161,708,815...161,721,986
Ensembl chr 1:161,708,812...161,721,782
G
HRH3
histamine receptor H3
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11125734 PMID:17276409
RGD:1626421
NCBI chr17:61,622,865...61,627,278
Ensembl chr17:61,622,938...61,627,278
G
HTR7
5-hydroxytryptamine receptor 7
ISO
RGD
PMID:18570192
RGD:6482184
NCBI chr14:102,443,312...102,548,894
Ensembl chr14:102,444,588...102,548,907
G
IL1A
interleukin 1 alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8003924
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,121
G
IL2
interleukin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8241462
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
IL6
interleukin 6
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9189931
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
NGF
nerve growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16405025 PMID:19694610
NCBI chr 4:105,256,691...105,307,843
Ensembl chr 4:105,256,749...105,307,837
G
PDYN
prodynorphin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7768285
NCBI chr17:33,505,075...33,521,534
Ensembl chr17:33,505,079...33,521,532
G
POMC
proopiomelanocortin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2841920
NCBI chr 3:113,661,712...113,668,558
Ensembl chr 3:113,661,004...113,670,418
G
PPARGC1A
PPARG coactivator 1 alpha
ISO
associated with morphine withdrawal syndrome;mRNA:increased expression:hippocamous (rat)
RGD
PMID:32198124
RGD:407571681
NCBI chr 8:17,841,844...18,527,953
Ensembl chr 8:17,841,844...17,946,992
G
PREP
prolyl endopeptidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8691432
NCBI chr 1:71,496,299...72,027,308
Ensembl chr 1:71,496,306...71,636,747
G
SIGMAR1
sigma non-opioid intracellular receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12028363
NCBI chr10:32,160,767...32,163,540
Ensembl chr10:32,160,822...32,164,718
G
TAC1
tachykinin precursor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7562510 PMID:9521815 PMID:20600432
NCBI chr 9:77,197,403...77,206,529
Ensembl chr 9:77,197,536...77,206,523
G
TRH
thyrotropin releasing hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7562510 PMID:7617693 PMID:8405091
NCBI chr13:69,362,892...69,366,183
Ensembl chr13:69,364,093...69,365,493
G
PREP
prolyl endopeptidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18318186
NCBI chr 1:71,496,299...72,027,308
Ensembl chr 1:71,496,306...71,636,747
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:18523723
RGD:2300277
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
POMC
proopiomelanocortin
ISO
protein:increased expression:mammillary body
RGD
PMID:1650797
RGD:407572523
NCBI chr 3:113,661,712...113,668,558
Ensembl chr 3:113,661,004...113,670,418
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all